Nanoparticle-mediated miR200-b delivery for the treatment of diabetic retinopathy.
about
Targeting noncoding RNAs in disease.MicroRNA-21 inhibits mitochondria-mediated apoptosis in keloid.Genomic form of rhodopsin DNA nanoparticles rescued autosomal dominant Retinitis pigmentosa in the P23H knock-in mouse model.A Naturally Fluorescent Mgp Transgenic Mouse for Angiogenesis and Glaucoma Longitudinal Studies.MicroRNA-200a/200b Modulate High Glucose-Induced Endothelial Inflammation by Targeting O-linked N-Acetylglucosamine Transferase Expression.
P2860
Nanoparticle-mediated miR200-b delivery for the treatment of diabetic retinopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nanoparticle-mediated miR200-b delivery for the treatment of diabetic retinopathy.
@en
Nanoparticle-mediated miR200-b delivery for the treatment of diabetic retinopathy.
@nl
type
label
Nanoparticle-mediated miR200-b delivery for the treatment of diabetic retinopathy.
@en
Nanoparticle-mediated miR200-b delivery for the treatment of diabetic retinopathy.
@nl
prefLabel
Nanoparticle-mediated miR200-b delivery for the treatment of diabetic retinopathy.
@en
Nanoparticle-mediated miR200-b delivery for the treatment of diabetic retinopathy.
@nl
P2093
P2860
P1476
Nanoparticle-mediated miR200-b delivery for the treatment of diabetic retinopathy.
@en
P2093
Chance A Nichols
Junjing Guo
Mark J Cooper
Muna I Naash
Rasha Makkia
P2860
P356
10.1016/J.JCONREL.2016.06.020
P407
P577
2016-06-10T00:00:00Z